Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Rapid molecular diagnostics for pathogen identification in hospital-acquired and ventilator-associated pneumonia in critical care: INHALE research programme including RCT›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

Rapid molecular diagnostics for pathogen identification in hospital-acquired and ventilator-associated pneumonia in critical care: INHALE research programme including RCT · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 6 min read

  1. Enne VI, Aydin A, Baldan R, Owen DR, Richardson H, Ricciardi F, et al. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study. Thorax 2022;77:1220–8. URL: https://discovery.ucl.ac.uk/id/eprint/10145520/ (accessed 5 December 2025).35027473
  2. Bello G, Pennisi MA, Di Muzio F, De Pascale G, Montini L, Maviglia R, et al. Clinical impact of pulmonary sampling site in the diagnosis of ventilator-associated pneumonia: a prospective study using bronchoscopic bronchoalveolar lavage. J Crit Care 2016;33:151–7.26993370
  3. Russell CD, Koch O, Laurenson IF, O’Shea DT, Sutherland R, Mackintosh CL. Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study. J Hosp Infect 2016;92:273–9.26810613
  4. Charalampous T, Kay GL, Richardson H, Aydin A, Baldan R, Jeanes C, et al. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection. Nat Biotechnol 2019;37:783–92.31235920
  5. Pan-ngum W, Blacksell SD, Lubell Y, Pukrittayakamee S, Bailey MS, de Silva HJ, et al. Estimating the true accuracy of diagnostic tests for dengue infection using Bayesian latent class models. PLOS ONE 2013;8:e50765.23349667
  6. Lim C, Paris DH, Blacksell SD, Laongnualpanich A, Kantipong P, Chierakul W, et al. How to determine the accuracy of an alternative diagnostic test when it is actually better than the reference tests: a re-evaluation of diagnostic tests for scrub typhus using Bayesian LCMs. PLOS ONE 2015;10:e0114930.26024375
  7. Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, Akerele O, et al. Multicenter evaluation of the BioFire FilmArray pneumonia/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol 2020;58:e00128.32350043
  8. Gadsby NJ, McHugh MP, Forbes C, MacKenzie L, Hamilton SKD, Griffith DM, Templeton KE. Comparison of Unyvero P55 Pneumonia Cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting. Eur J Clin Microbiol Infect Dis 2019;38:1171–8.30859358
  9. Pickens C, Wunderink RG, Qi C, Mopuru H, Donnelly H, Powell K, Sims MD. A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia. Diagn Microbiol Infect Dis 2020;98:115179.32927409
  10. Webber DM, Wallace MA, Burnham CAD, Anderson NW. Evaluation of the BioFire FilmArray Pneumonia Panel for detection of viral and bacterial pathogens in lower respiratory tract specimens in the setting of a tertiary care Academic Medical Center. J Clin Microbiol 2020;58:e00343.32321782
  11. Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med 2020;46:888–906.32157357
  12. Melsen WG, Rovers MM, Groenwold RHH, Bergmans DCJJ, Camus C, Bauer TT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013;13:665–71.23622939
  13. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013;173:2039–46.23999949
  14. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707–10.8844239
  15. Leteurtre S, Duhamel A, Salleron J, Grandbastien B, Lacroix J, Leclerc F; Groupe Francophone de Réanimation et d’Urgences Pédiatriques (GFRUP). PELOD-2: an update of the PEdiatric logistic organ dysfunction score. Crit Care Med 2013;41:1761–73.23685639
  16. Enne VI, Stirling S, Barber JA, High J, Russell C, Brealey D, et al. INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia. Intensive Care Med 2025;51:272–86. 10.1007/s00134-024-07772-239961847
  17. High J, Enne VI, Barber JA, Brealey D, Turner DA, Horne R, et al.; INHALE Study Group. INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care – study protocol for a multicentre randomised controlled trial. Trials 2021;22:680.34620213
  18. Agresti A, Caffo B. Simple and effective confidence intervals for proportions and differences of proportions result from adding two successes and two failures. Am Stat 2000;54:280–8.
  19. European Medicines Agency. Guideline on the Evaluation of Medicinal Products Indicated for Treatment of Bacterial Infections. London: European Medicines Agency; 2011.
  20. Mathioudakis AG, Fally M, Hansel J, Robey RC, Haseeb F, Williams T, et al.; Pneumonia Outcomes Group. Clinical trials of pneumonia management assess heterogeneous outcomes and measurement instruments. J Clin Epidemiol 2023;164:88–95.37898460
  21. Pandolfo A, Horne R, Jani Y, et al. Understanding decisions about antibiotic prescribing in ICU: an application of the Necessity Concerns Framework. BMJ Quality and Safety 2022;31:199–210.
  22. Fine MA, Kurdek LA. Publishing multiple journal articles from a single data set: issues and recommendations. J Fam Psychol 1994;8:371–9.
  23. Pandolfo A, Horne R, Jani Y, Reader TW, Bidad N, Brealey D, et al. Intensivists’ beliefs about rapid multiplex molecular diagnostic testing and its potential role in improving prescribing decisions and antimicrobial stewardship: a qualitative study. Antimicrob Resist Infect Contr 2021;10:95.
  24. Stewart SF, Pandolfo AM, Jani Y, Moon Z, Brealey D, Enne VI, et al. 2025 Guidelines vs mindlines: a qualitative investigation of how clinicians’ beliefs influence the application of rapid molecular diagnostics in intensive care. Antimicrob Agents Chemother 2025;69:e0115624.39907301
  25. Stewart SJF, Enne VI, Pandolfo AM, Jani YH, Brealey D, Brett SJ, et al. Machine says yes, doctor says no: an ecological momentary assessment analysis examining clinicians' perceptions of, and their antibiotic prescribing behaviour when using rapid molecular diagnostic tests in intensive care. Antimicrob Resist Infect Control 2026;15:42. 10.1186/s13756-025-01690-841877199
  26. Edwards SJ, Wordsworth S, Clarke MJ. Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost–utility analysis comparing meropenem with piperacillin/tazobactam. Eur J Health Econ 2012;13:181–92.21243514
  27. Wagner AP, Enne VI, Livermore DM, Craig JV, Turner DA. A review of health economic models and Ventilator Associated pneumonia (VAP). J Hosp Infect 2020;106:745–56. URL: https://discovery.ucl.ac.uk/id/eprint/10123475 (accessed 5 December 2025).32971194
  28. Wagner AP, Enne VI, Gant V, Stirling S, Barber JA, Livermore DM, et al. Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT. Critical Care 2025;29:352.40781331
  29. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36.21479777
  30. Hernández Alava M, Pudney S, Wailoo A. Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study. PharmacoEconomics 2023;41:199–207.36449173
  31. Darie AM, Khanna N, Jahn K, Osthoff M, Bassetti S, Osthoff M, et al. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 2022;10:877–87.35617987
  32. Poole S, Tanner AR, Naidu VV, Borca F, Phan H, Saeed K, et al. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: results of a randomised controlled trial. J Infect 2022;85:625–33.36096312
  33. Langelier C, Kalantar KL, Moazed F, Wilson MR, Crawford ED, Deiss T, et al. Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proc Natl Acad Sci USA 2018;115:E12353–62.30482864
  34. Collins CD, Schwemm AK. Linezolid versus vancomycin in the empiric treatment of nosocomial pneumonia: a cost–utility analysis incorporating results from the ZEPHyR trial. Value Health 2015;18:614–21.26297089
  35. Drummond M, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programme. 3rd edn. Oxford: University Press; 2005.
  36. Jones KB. A Unit Costs of Health and Social Care 2021. Canterbury: Personal Social Services Research Unit, University of Kent; 2021.
← SynopsisAdditional information →

Attribution. Virve I Enne; Sarah-Jane F Stewart; Adam P Wagner; David Turner; Charlotte Russell; Juliet High et al. (2026). Rapid molecular diagnostics for pathogen identification in hospital-acquired and ventilator-associated pneumonia in critical care: INHALE research programme including RCT. National Institute for Health and Care Research. Copyright © 2026 Enne et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK623091. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support